Next-generation sequencing in oncology: genetic diagnosis, risk prediction and cancer classification

R Kamps, RD Brandão, BJ van den Bosch… - International journal of …, 2017 - mdpi.com
Next-generation sequencing (NGS) technology has expanded in the last decades with
significant improvements in the reliability, sequencing chemistry, pipeline analyses, data …

Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine in cancer

S Morganti, P Tarantino, E Ferraro, P D'Amico… - … research and onco …, 2019 - Springer
Following the completion of the Human Genome Project in 2003, research in oncology has
progressively focused on the sequencing of cancer genomes, with the aim of better …

Genome-wide association study for feed efficiency and growth traits in US beef cattle

CM Seabury, DL Oldeschulte, M Saatchi, JE Beever… - BMC genomics, 2017 - Springer
Background Single nucleotide polymorphism (SNP) arrays for domestic cattle have
catalyzed the identification of genetic markers associated with complex traits for inclusion in …

[HTML][HTML] Dihydropyrimidine accumulation is required for the epithelial-mesenchymal transition

YD Shaul, E Freinkman, WC Comb, JR Cantor… - Cell, 2014 - cell.com
It is increasingly appreciated that oncogenic transformation alters cellular metabolism to
facilitate cell proliferation, but less is known about the metabolic changes that promote …

Pathophysiological role of purines and pyrimidines in neurodevelopment: unveiling new pharmacological approaches to congenital brain diseases

M Fumagalli, D Lecca, MP Abbracchio… - Frontiers in …, 2017 - frontiersin.org
In recent years, a substantial body of evidence has emerged demonstrating that purine and
pyrimidine synthesis and metabolism play major roles in controlling embryonic and fetal …

Metabolic seizures

M Almannai, RA Al Mahmoud, M Mekki… - Frontiers in …, 2021 - frontiersin.org
Metabolic diseases should always be considered when evaluating children presenting with
seizures. This is because many metabolic disorders are potentially treatable and seizure …

Genotypes affecting the pharmacokinetics of anticancer drugs

D Bertholee, JG Maring, ABP van Kuilenburg - Clinical pharmacokinetics, 2017 - Springer
Cancer treatment is becoming more and more individually based as a result of the large
inter-individual differences that exist in treatment outcome and toxicity when patients are …

DPD testing before treatment with fluoropyrimidines in the Amsterdam UMCs: an evaluation of current pharmacogenetic practice

FK Martens, DW Huntjens, T Rigter, M Bartels… - Frontiers in …, 2020 - frontiersin.org
Introduction The fluoropyrimidines (FP)(5-Fluorouracil, capecitabine, and tegafur) are
commonly used anti-cancer drugs, but lead to moderate to severe toxicity in about 10–40 …

[HTML][HTML] Carnosine and related peptides: therapeutic potential in age-related disorders

JH Cararo, EL Streck, PF Schuck… - Aging and …, 2015 - ncbi.nlm.nih.gov
Imidazole dipeptides (ID), such as carnosine (β-alanyl-L-histidine), are compounds widely
distributed in excitable tissues of vertebrates. ID are also endowed of several biochemical …

[HTML][HTML] Phenotypic and clinical implications of variants in the dihydropyrimidine dehydrogenase gene

ABP van Kuilenburg, J Meijer, MWT Tanck… - … et Biophysica Acta (BBA …, 2016 - Elsevier
Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the
catabolism of the pyrimidine bases uracil, thymine and the antineoplastic agent 5 …